Reproducibility of serologic assays for influenza virus A (H5N1).
Reproducibility of serologic assays for influenza virus A (H5N1).
复制标题
DOI:
10.3201/eid1508.081754
复制
发表时间:
2009-08
影响因子:
11.8
通讯作者:
Wood JM
中科院分区:
文献类型:
--
作者:
Stephenson I;Heath A;Major D;Newman RW;Hoschler K;Junzi W;Katz JM;Weir JP;Zambon MC;Wood JM
Results for clade 1 viruses were more consistent among laboratories when a standard antibody was used. Hemagglutination-inhibition (HI) and neutralization are used to evaluate vaccines against influenza virus A (H5N1); however, poor standardization leads to interlaboratory variation of results. A candidate antibody standard (07/150) was prepared from pooled plasma of persons given clade 1 A/Vietnam/1194/2004 vaccine. To test human and sheep antiserum, 15 laboratories used HI and neutralization and reassortant A/Vietnam/1194/2004, A/turkey/Turkey/1/2005 (clade 2.2), and A/Anhui/1/2005 (clade 2.3.4) viruses. Interlaboratory variation was observed for both assays, but when titers were expressed relative to 07/150, overall percentage geometric coefficient of variation for A/Vietnam/1194/2004 was reduced from 125% to 61% for HI and from 183% to 81% for neutralization. Lack of reduced variability to clade 2 antigens suggested the need for clade-specific standards. Sheep antiserum as a standard did not reliably reduce variability. The World Health Organization has established 07/150 as an international standard for antibody to clade 1 subtype H5 and has an assigned potency of 1,000 IU/ampoule.
登录
查看更多内容
影响因子:
168.9
作者:
Nicholson, KG;Colegate, AE;Zambon, MC
通讯作者:
Zambon, MC
影响因子:
5.5
作者:
Gulati, U;Kumari, K;Air, GM
通讯作者:
Air, GM
影响因子:
9.4
作者:
OKUNO, Y;TANAKA, K;UEDA, S
通讯作者:
UEDA, S
影响因子:
1.7
作者:
Ferguson, M;Heath, A
通讯作者:
Heath, A
影响因子:
5.5
作者:
WOOD, JM;GAINESDAS, RE;CHAKRAVERTY, P
通讯作者:
CHAKRAVERTY, P